Daniel J. No

4.7k total citations · 3 hit papers
21 papers, 3.4k citations indexed

About

Daniel J. No is a scholar working on Dermatology, Molecular Biology and Immunology. According to data from OpenAlex, Daniel J. No has authored 21 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Dermatology, 8 papers in Molecular Biology and 7 papers in Immunology. Recurrent topics in Daniel J. No's work include Dermatology and Skin Diseases (7 papers), Psoriasis: Treatment and Pathogenesis (7 papers) and Gut microbiota and health (5 papers). Daniel J. No is often cited by papers focused on Dermatology and Skin Diseases (7 papers), Psoriasis: Treatment and Pathogenesis (7 papers) and Gut microbiota and health (5 papers). Daniel J. No collaborates with scholars based in United States, Denmark and Canada. Daniel J. No's co-authors include Eric G. Pamer, Asia Gobourne, Lilan Ling, Eric R. Littmann, Agnès Viale, Marcel R.M. van den Brink, Robert R. Jenq, Ying Taur, Nora C. Toussaint and Vanni Bucci and has published in prestigious journals such as Nature, Nature Communications and Blood.

In The Last Decade

Daniel J. No

19 papers receiving 3.3k citations

Hit Papers

Precision microbiome reconstitution restores bile acid me... 2014 2026 2018 2022 2014 2016 2014 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel J. No United States 12 2.1k 1.4k 917 504 471 21 3.4k
Eric R. Littmann United States 18 2.8k 1.3× 1.9k 1.4× 1.1k 1.2× 733 1.5× 394 0.8× 35 4.3k
Asia Gobourne United States 9 3.0k 1.4× 2.2k 1.6× 1.1k 1.2× 784 1.6× 431 0.9× 10 4.6k
Andrew Y. Koh United States 28 2.2k 1.0× 1.1k 0.8× 758 0.8× 582 1.2× 791 1.7× 70 3.7k
Annemarie Boleij Netherlands 26 2.6k 1.3× 775 0.6× 1.2k 1.3× 732 1.5× 216 0.5× 45 4.0k
Janelle C. Arthur United States 33 3.6k 1.7× 918 0.7× 972 1.1× 572 1.1× 1.5k 3.1× 53 5.5k
Temitope O. Keku United States 39 3.8k 1.8× 715 0.5× 2.0k 2.2× 648 1.3× 381 0.8× 134 6.6k
Filippo Canducci Italy 29 1.2k 0.6× 1.1k 0.8× 256 0.3× 843 1.7× 359 0.8× 79 3.5k
Joseph P. Zackular United States 18 1.7k 0.8× 670 0.5× 416 0.5× 354 0.7× 199 0.4× 46 2.3k
Nadia Vasquez France 11 3.2k 1.5× 1.1k 0.8× 208 0.2× 530 1.1× 257 0.5× 16 4.0k
Natalia Borruel Spain 25 2.1k 1.0× 772 0.6× 205 0.2× 894 1.8× 447 0.9× 73 3.8k

Countries citing papers authored by Daniel J. No

Since Specialization
Citations

This map shows the geographic impact of Daniel J. No's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel J. No with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel J. No more than expected).

Fields of papers citing papers by Daniel J. No

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel J. No. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel J. No. The network helps show where Daniel J. No may publish in the future.

Co-authorship network of co-authors of Daniel J. No

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel J. No. A scholar is included among the top collaborators of Daniel J. No based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel J. No. Daniel J. No is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
No, Daniel J., et al.. (2022). A case of histiocytoid angiosarcoma mimicking Rosai‐Dorfman disease histopathologically. Journal of Cutaneous Pathology. 49(6). 589–592.
2.
Wu, Jashin J., Caroline Amand, Daniel J. No, et al.. (2021). The Use of Real-World Data to Evaluate the Association Between Atopic Dermatitis and Cardiovascular Disease: A Retrospective Claims Analysis. Dermatology and Therapy. 11(5). 1707–1715. 9 indexed citations
3.
Malakouti, Mona, et al.. (2018). Methotrexate. Journal of the Dermatology Nurses’ Association. 10(2). 92–94. 2 indexed citations
4.
Amin, Mina, Daniel J. No, Alexander Egeberg, & Jashin J. Wu. (2017). Choosing First-Line Biologic Treatment for Moderate-to-Severe Psoriasis: What Does the Evidence Say?. American Journal of Clinical Dermatology. 19(1). 1–13. 62 indexed citations
5.
No, Daniel J., et al.. (2017). Review of phase III trial data on IL‐23 inhibitors tildrakizumab and guselkumab for psoriasis. Journal of the European Academy of Dermatology and Venereology. 31(10). 1627–1632. 22 indexed citations
6.
No, Daniel J., Megan S. Inkeles, Mina Amin, & Jashin J. Wu. (2017). Drug survival of biologic treatments in psoriasis: a systematic review. Journal of Dermatological Treatment. 29(5). 460–466. 68 indexed citations
7.
Amin, Mina, Daniel J. No, & Jashin J. Wu. (2017). Review of U.S. registries for psoriasis. Journal of Dermatological Treatment. 28(8). 697–701. 5 indexed citations
8.
No, Daniel J., Mina Amin, Tina Bhutani, & Jashin J. Wu. (2017). A systematic review of active comparator controlled clinical trials in patients with moderate-to-severe psoriasis. Journal of Dermatological Treatment. 29(5). 467–474. 7 indexed citations
9.
No, Daniel J., Mina Amin, Alexander Egeberg, Jacob P. Thyssen, & Jashin J. Wu. (2017). Atopic dermatitis 2017: where we were 10–15 years ago in psoriasis. Journal of Dermatological Treatment. 29(1). 100–101. 2 indexed citations
10.
Inkeles, Megan S., Daniel J. No, & Jashin J. Wu. (2017). Clinical improvement of a patient with both amyopathic dermatomyositis and psoriasis following treatment with cyclosporine. Dermatology Online Journal. 23(8). 4 indexed citations
11.
Amin, Mina, et al.. (2017). Review of IL-17 inhibitors for psoriasis. Journal of Dermatological Treatment. 29(4). 347–352. 18 indexed citations
12.
Dubin, Krista, Margaret K. Callahan, Boyu Ren, et al.. (2016). Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis. Nature Communications. 7(1). 10391–10391. 773 indexed citations breakdown →
13.
Kinnebrew, Melissa A., Yeon Joo Lee, Robert R. Jenq, et al.. (2014). Early Clostridium difficile Infection during Allogeneic Hematopoietic Stem Cell Transplantation. PLoS ONE. 9(3). e90158–e90158. 55 indexed citations
14.
Buffie, Charlie G., Vanni Bucci, Richard R. Stein, et al.. (2014). Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature. 517(7533). 205–208. 1332 indexed citations breakdown →
15.
Taur, Ying, Robert R. Jenq, Miguel‐Angel Perales, et al.. (2014). The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation. Blood. 124(7). 1174–1182. 614 indexed citations breakdown →
16.
Úbeda, Carles, Vanni Bucci, Silvia Caballero, et al.. (2013). Intestinal Microbiota Containing Barnesiella Species Cures Vancomycin-Resistant Enterococcus faecium Colonization. Infection and Immunity. 81(3). 965–973. 344 indexed citations
17.
No, Daniel J., et al.. (2013). Novel GNE Mutations in Autosomal Recessive Hereditary Inclusion Body Myopathy Patients. Genetic Testing and Molecular Biomarkers. 17(5). 376–382. 7 indexed citations
18.
No, Daniel J., et al.. (2011). Serum Neural Cell Adhesion Molecule Is Hyposialylated in Hereditary Inclusion Body Myopathy. Genetic Testing and Molecular Biomarkers. 16(5). 313–317. 13 indexed citations
19.
No, Daniel J., et al.. (2011). Wolman Disease (LIPA p.G87V) Genotype Frequency in People of Iranian-Jewish Ancestry. Genetic Testing and Molecular Biomarkers. 15(6). 395–398. 27 indexed citations
20.
No, Daniel J., Steven J. Shook, Jerry R. Mendell, et al.. (2010). Novel GNE Mutations in Hereditary Inclusion Body Myopathy Patients of Non-Middle Eastern Descent. Genetic Testing and Molecular Biomarkers. 14(2). 157–162. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026